Mineralys Therapeutics Files 8-K
Ticker: MLYS · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1933414
Sentiment: neutral
Topics: 8-K, disclosure, corporate-events
TL;DR
Mineralys Therapeutics filed an 8-K on 3/31 for events on 3/29 - check for updates.
AI Summary
Mineralys Therapeutics, Inc. filed an 8-K on March 31, 2025, reporting events that occurred on March 29, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in Radnor, Pennsylvania.
Why It Matters
This 8-K filing provides an update on corporate events and financial disclosures for Mineralys Therapeutics, Inc., which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any significant new risks or material adverse information.
Key Players & Entities
- Mineralys Therapeutics, Inc. (company) — Registrant
- March 29, 2025 (date) — Date of earliest event reported
- March 31, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Radnor, Pennsylvania (location) — Address of principal executive offices
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text.
What 'Other Events' are being reported by Mineralys Therapeutics?
The filing lists 'Other Events' as an item information category, but the specific nature of these events is not detailed in the provided text.
When was Mineralys Therapeutics, Inc. incorporated?
Mineralys Therapeutics, Inc. was incorporated in Delaware.
What is the primary business of Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
What is the SEC file number for Mineralys Therapeutics, Inc.?
The SEC file number for Mineralys Therapeutics, Inc. is 001-41614.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Mineralys Therapeutics, Inc. (MLYS).